Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
1.
Urol Case Rep ; 11: 37-38, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28083485

ABSTRACT

A 46-year old man with X-linked chronic granulomatous disease (CGD) being followed at the National Institute of Health with uncontrolled CGD colitis who developed chronic colovesical fistula, and end-stage renal disease (ESRD). Despite aggressive medical management of symptoms with immunomodulators and antibiotic prophylaxis, the chronic colovesical fistula led to chronic pyelonephritis, recurrent urinary tract infections, persistent air in the collecting system and bladder, and post-renal obstruction resulting in renal failure. Patient is now hemodialysis dependent and required diverting loop ileostomy placement. This report highlights multiple potential etiologies of rising serum creatinine in patients with CGD.

2.
Br J Anaesth ; 105(6): 760-6, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20935004

ABSTRACT

BACKGROUND: Although the increasing abundance of CO(2) in our atmosphere is the main driver of the observed climate change, it is the cumulative effect of all forcing agents that dictate the direction and magnitude of the change, and many smaller contributors are also at play. Isoflurane, desflurane, and sevoflurane are widely used inhalation anaesthetics. Emissions of these compounds contribute to radiative forcing of climate change. To quantitatively assess the impact of the anaesthetics on the forcing of climate, detailed information on their properties of heat (infrared, IR) absorption and atmospheric lifetimes are required. METHODS: We have measured the IR spectra of these anaesthetics and conducted calculations of their contribution to radiative forcing of climate change recognizing the important fact that radiative forcing is strongly dependent on the wavelength of the absorption features. RESULTS: Radiative efficiencies of 0.453, 0.469, and 0.351 W m(-2) ppb(-1) and global warming potentials (GWPs) of 510, 1620, and 210 (100 yr time horizon) were established for isoflurane, desflurane, and sevoflurane, respectively. CONCLUSIONS: On the basis of the derived 100 yr GWPs, the average climate impact per anaesthetic procedure at the University of Michigan is the same as the emission of ∼22 kg CO(2). We estimate that the global emissions of inhalation anaesthetics have a climate impact which is comparable with that from the CO(2) emissions from one coal-fired power plant or 1 million passenger cars.


Subject(s)
Air Pollutants/chemistry , Anesthetics, Inhalation/chemistry , Global Warming , Atmosphere/chemistry , Carbon Dioxide/chemistry , Desflurane , Humans , Isoflurane/analogs & derivatives , Isoflurane/chemistry , Methyl Ethers/chemistry , Sevoflurane , Spectrophotometry, Infrared/methods
3.
Phys Rev Lett ; 98(6): 065003, 2007 Feb 09.
Article in English | MEDLINE | ID: mdl-17358953

ABSTRACT

Axial symmetry in x-ray radiation of wire-array z pinches is important for the creation of dynamic hohlraums used to compress inertial-confinement-fusion capsules. We present the first evidence that this symmetry is directly correlated with the magnitude of the negative radial electric field along the wire surface. This field (in turn) is inferred to control the initial energy deposition into the wire cores, as well as any current shorting to the return conductor.

4.
J Am Soc Nephrol ; 13(1): 184-190, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11752036

ABSTRACT

Diets enriched with fish oil may favorably affect the vascular perturbations underlying synthetic graft thrombosis. Therefore, these studies were designed to test the hypothesis that diets enriched with fish oil would decrease the incidence of thrombosis in newly constructed polytetrafluorethylene grafts. A double-blind, randomized trial was conducted. Twenty-four patients were randomized to receive 4000 mg of fish oil or 4000 mg of control oil. Both preparations were enriched with antioxidants and deodorized with peppermint. Patients began therapy within 2 wk after graft placement and were monitored for 12 mo or until thrombosis developed. With a permuted-block randomization schedule, 12 patients received fish oil and 12 patients received control oil. The primary patency rates at 365 d were 14.9% for the control group and 75.6% for the fish oil-treated group. Survival analysis revealed a significant difference between fish oil-treated and untreated patients (P < 0.03, Mantel-Cox test), with a power of 90%. Moreover, analysis of covariables, including age of > or =50 yr, gender, race, body weight, diabetes mellitus, bleeding times, and lipid profiles, indicated that this effect occurred principally as a result of fish oil administration. Importantly, fish oil treatment also decreased venous outflow resistance and systemic BP, compared with control values. Fish oils possess unique biologic properties that favorably affect the incidence of polytetrafluorethylene graft thrombosis, and they thus represent a potential treatment strategy for the prevention of access thrombosis.


Subject(s)
Blood Vessel Prosthesis/adverse effects , Fish Oils/therapeutic use , Renal Dialysis , Thrombosis/prevention & control , Administration, Oral , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Blood Pressure/drug effects , Calcium Channel Blockers/therapeutic use , Corn Oil/therapeutic use , Double-Blind Method , Female , Fish Oils/administration & dosage , Humans , Male , Middle Aged , Polytetrafluoroethylene , Proportional Hazards Models , Prospective Studies
5.
Disabil Rehabil ; 24(17): 899-903, 2002 Nov 20.
Article in English | MEDLINE | ID: mdl-12519485

ABSTRACT

PURPOSE: Women with spinal cord injury (SCI) and other physical disabilities often lack access to appropriate gynecologic health care and may be at higher risk for preventable gynecologic diseases and other health problems. The purpose of this study was to investigate the effects of a women's health clinic that was established to meet the needs of women with SCI and other disabilities. Specifically, this study examined the effect of clinic participation upon the rate of preventive gynecologic health care behaviours and assessed the relationship between physical and emotional functioning in women with SCI and other disabilities. METHOD: Participants (n =28) were women who completed surveys immediately prior to participation in the clinic, and at 3 and 12 month follow-ups. RESULTS: Results indicated a trend towards increased frequency of breast self-exam three months after initial participation in the clinic (p =0.11). Other rates of health promoting behaviours (exercise, diet and mammography) did not increase. Results also indicated that although physical functioning and life satisfaction were not related, women in this study did experience moderate to high levels of psychological distress. CONCLUSION: Results indicate that whole-woman health care may be important to increasing certain health behaviours among women with disabilities. Implications for comprehensive treatment are discussed.


Subject(s)
Gynecology , Health Behavior , Health Services Accessibility , Spinal Cord Injuries/rehabilitation , Women's Health , Adolescent , Adult , Breast Self-Examination/psychology , Disabled Persons , Feeding Behavior/psychology , Female , Humans , Mammography/psychology , Middle Aged , Missouri , Quality of Life , Spinal Cord Injuries/psychology , Time Factors
6.
Arch Otolaryngol Head Neck Surg ; 127(10): 1253-9, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11587608

ABSTRACT

Cyclooxygenase (COX) is the rate-limiting enzyme in the formation of prostaglandins from arachidonic acid. COX exists in 2 isoforms, COX-1 and COX-2. These isoforms are encoded by separate genes and demonstrate cell-specific expression and regulation. Peroxisome proliferator-activated receptor delta (PPARdelta) is a nuclear transcription factor that is activated by prostacyclin. Vascular endothelial growth factor (VEGF) is a proangiogenic factor that is up-regulated in various tumors. Vascular endothelial growth factor has been shown to interact with COX-derived prostaglandins in angiogenesis. To better understand the roles of these genes in head and neck squamous cell carcinoma (HNSCCA), we examined the differential expression of the COX1, COX2, VEGF, and PPARdelta genes in these tumors. Tissue samples from patients with HNSCCA were analyzed for COX-1, COX-2, VEGF, and PPARdelta messenger RNAs (mRNAs) by in situ hybridization. COX-1 and COX-2 mRNAs were also evaluated with Northern blot hybridization. Immunohistochemistry was used to analyze for COX-2 and PPARdelta proteins. Results showed focal areas of accumulation for COX-2, VEGF, and PPARdelta but not COX-1 in human HNSCCA. Northern blot hybridization showed higher levels of COX-2 mRNA in HNSCCA than in normal tissue. This suggests a supportive role of COX-2 in development and/or progression of HNSCCA. In addition, PPARdelta may be a receptor for COX-2-produced prostaglandins in HNSCCA. There is a potential role for selective COX-2 inhibitors in the treatment of these lesions.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Endothelial Growth Factors/genetics , Head and Neck Neoplasms/metabolism , Isoenzymes/genetics , Lymphokines/genetics , Prostaglandin-Endoperoxide Synthases/genetics , Receptors, Cytoplasmic and Nuclear/genetics , Transcription Factors/genetics , Blotting, Northern , Carcinoma, Squamous Cell/pathology , Cyclooxygenase 1 , Cyclooxygenase 2 , Head and Neck Neoplasms/pathology , Humans , Immunohistochemistry , In Situ Hybridization , Lymph Nodes/metabolism , Lymphatic Metastasis , Membrane Proteins , RNA, Messenger/analysis , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
7.
J Bone Miner Res ; 15(3): 442-50, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10750558

ABSTRACT

The EXT genes are a group of putative tumor suppressor genes that previously have been shown to participate in the development of hereditary multiple exostoses (HME), HME-associated and isolated chondrosarcomas. Two HME disease genes, EXT1 and EXT2, have been identified and are expressed ubiquitously. However, the only known effect of mutations in the EXT genes is on chondrocyte function as evidenced by aberrant proliferation of chondrocytes leading to formation of bony, cartilage-capped projections (exostoses). In this study, we have characterized exostosis chondrocytes from three patients with HME (one with EXT1 and two with EXT2 germline mutations) and from one individual with a non-HME, isolated exostosis. At the light microscopic level, exostosis chondrocytes have a stellate appearance with elongated inclusions in the cytoplasm. Confocal and immunofluorescence of in vitro and in vivo chondrocytes showed that these massive accumulations are composed of actin bundled by 1.5-microm repeat cross-bridges of alpha-actinin. Western blot analysis shows that exostosis chondrocytes from two out of three patients aberrantly produce high levels of muscle-specific alpha-actin, whereas beta-actin levels are similar to normal chondrocytes. These findings suggest that mutations in the EXT genes cause abnormal processing of cytoskeleton proteins in chondrocytes.


Subject(s)
Actins/metabolism , Cartilage/pathology , Cytoskeleton/pathology , Exostoses, Multiple Hereditary/genetics , N-Acetylglucosaminyltransferases , Protein Isoforms/metabolism , Proteins/genetics , Vimentin/metabolism , Actinin/metabolism , Blotting, Western , Cartilage/chemistry , Child , DNA Mutational Analysis , Exostoses/genetics , Exostoses/pathology , Exostoses, Multiple Hereditary/pathology , Humans , Macromolecular Substances , Microscopy, Confocal , Microscopy, Fluorescence , Proteins/physiology
9.
Ann Otol Rhinol Laryngol ; 108(11 Pt 1): 1073-7, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10579235

ABSTRACT

The role of human papillomavirus (HPV) in airway papillomas has been well defined in recent literature. The chronicity and recurrence of papillomas has been postulated to be a result of residual viral genome in tissue treated with standard laser techniques. Thirteen patients with airway papillomas were selected for study with polymerase chain reaction (PCR) methods to detect viral DNA. Specimens taken prior to laser therapy and specimens taken at laser margins were consistently positive for HPV DNA by PCR. The HPV DNA is apparently present in tissues after macroscopic disease has been ablated by laser techniques. Histologic analysis of laser biopsies demonstrated fragments of squamous epithelium with cytologic features of HPV infection. Laser treatment is ineffective in eradicating HPV-infected tissues from airway papillomas, and this finding supports the notion that recurrence is a product of HPV incorporated into tissue not ablated by laser irradiation. Specific methods, results, and clinical correlation will be discussed.


Subject(s)
Laryngeal Neoplasms/virology , Nose Neoplasms/virology , Papilloma/virology , Papillomaviridae/isolation & purification , Papillomavirus Infections/virology , Tumor Virus Infections/virology , Adult , Biopsy , Child , Child, Preschool , DNA, Viral/isolation & purification , Female , Humans , Laryngeal Neoplasms/pathology , Laryngeal Neoplasms/surgery , Laser Therapy , Male , Nose Neoplasms/pathology , Nose Neoplasms/surgery , Papilloma/pathology , Papilloma/surgery , Papillomavirus Infections/pathology , Papillomavirus Infections/surgery , Polymerase Chain Reaction , Recurrence , Tumor Virus Infections/pathology , Tumor Virus Infections/surgery
11.
Am J Med Genet ; 85(5): 486-90, 1999 Aug 27.
Article in English | MEDLINE | ID: mdl-10405447

ABSTRACT

Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (EDM1) are allelic disorders caused by mutations in the gene encoding cartilage oligomeric matrix protein (COMP). PSACH is a dominant condition characterized by disproportionate short stature, joint laxity, and early-onset osteoarthritis. EDM1 is a less severe skeletal dysplasia associated with average to mild short stature, joint pain, and early-onset osteoarthritis. COMP is an extracellular matrix protein present in cartilage, ligament, and tendon tissues. Here, we report on nine novel mutations in COMP causing PSACH and EDM1. Four of these mutations are in exons 13C and 14 where no previous mutations had been reported. One of those mutations was identified in two separate EDM1 families. In addition, we have identified the first case of PSACH resulting from an expansion of the five aspartates in exon 17B. We are also reporting a mutation in a third PSACH family with somatic/germline mosaicism. Therefore, this report increases the range of mutations that cause PSACH and EDM1 and provides additional regions to target for mutational analysis.


Subject(s)
Achondroplasia/genetics , Epiphyses/abnormalities , Extracellular Matrix Proteins/genetics , Glycoproteins/genetics , Mutation , Osteochondrodysplasias/genetics , Polymorphism, Single-Stranded Conformational , Cartilage , Cartilage Oligomeric Matrix Protein , Exons , Female , Germ-Line Mutation , Humans , Male , Matrilin Proteins , Mosaicism , Pedigree , Polymerase Chain Reaction
12.
Laryngoscope ; 109(7 Pt 1): 1137-41, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10401857

ABSTRACT

OBJECTIVES: Demonstrate the induction of cyclooxygenase-2 (COX-2) in laryngeal papilloma Discuss the possible causal role of COX-2 in papilloma formation. Consider the potential for treatment of papilloma using selective COX-2 inhibitors. STUDY DESIGN: Molecular biological analysis of COX-1 and COX-2 in laryngeal papilloma. METHODS: Tissue samples from five patients with recurrent respiratory papillomatosis (RRP) were analyzed by in situ hybridization, immunohistochemical staining, and reverse transcription polymerase chain reaction (RT-PCR) techniques. RESULTS: In situ hybridization to COX-2 mRNA showed strong autoradiographic signal surrounding fibrovascular cores. COX-1 autoradiographic signal was low intensity or nondetectable. Normal buccal mucosa biopsies showed low-density or nondetectable autoradiographic signal for both COX-1 and COX-2 mRNAs. In situ hybridization results were corroborated by RT-PCR studies. Levels of COX-2 mRNA were 13-fold more than those in normal mucosa. Immunohistochemical staining for COX-1 and COX-2 showed a similar pattern to that seen with in situ hybridization in both normal and papilloma tissues. CONCLUSIONS: There is an elevation of COX-2 expression in papilloma tissues. This may represent a causal role of COX-2 in the formation and proliferation of laryngeal papilloma. There may also be a role for selective COX-2 inhibition for the treatment of


Subject(s)
Laryngeal Neoplasms/enzymology , Papilloma/enzymology , Prostaglandin-Endoperoxide Synthases/analysis , Autoradiography , Blotting, Southern , Cyclooxygenase 1 , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/therapeutic use , Humans , Immunohistochemistry , In Situ Hybridization , Isoenzymes/analysis , Laryngeal Neoplasms/drug therapy , Membrane Proteins , Neoplasm Recurrence, Local/enzymology , Papilloma/drug therapy , Polymerase Chain Reaction , RNA-Directed DNA Polymerase
13.
J Cell Biol ; 145(5): 1103-15, 1999 May 31.
Article in English | MEDLINE | ID: mdl-10352025

ABSTRACT

Expression of the basement membrane heparan sulfate proteoglycan (HSPG), perlecan (Pln), mRNA, and protein has been examined during murine development. Both Pln mRNA and protein are highly expressed in cartilaginous regions of developing mouse embryos, but not in areas of membranous bone formation. Initially detected at low levels in precartilaginous areas of d 12.5 embryos, Pln protein accumulates in these regions through d 15.5 at which time high levels are detected in the cartilage primordia. Laminin and collagen type IV, other basal lamina proteins commonly found colocalized with Pln, are absent from the cartilage primordia. Accumulation of Pln mRNA, detected by in situ hybridization, was increased in d 14.5 embryos. Cartilage primordia expression decreased to levels similar to that of the surrounding tissue at d 15.5. Pln accumulation in developing cartilage is preceded by that of collagen type II. To gain insight into Pln function in chondrogenesis, an assay was developed to assess the potential inductive activity of Pln using multipotential 10T1/2 murine embryonic fibroblast cells. Culture on Pln, but not on a variety of other matrices, stimulated extensive formation of dense nodules reminiscent of embryonic cartilaginous condensations. These nodules stained intensely with Alcian blue and collagen type II antibodies. mRNA encoding chondrocyte markers including collagen type II, aggrecan, and Pln was elevated in 10T1/2 cells cultured on Pln. Human chondrocytes that otherwise rapidly dedifferentiate during in vitro culture also formed nodules and expressed high levels of chondrocytic marker proteins when cultured on Pln. Collectively, these studies demonstrate that Pln is not only a marker of chondrogenesis, but also strongly potentiates chondrogenic differentiation in vitro.


Subject(s)
Chondrocytes/metabolism , Embryonic and Fetal Development , Heparan Sulfate Proteoglycans , Heparitin Sulfate/biosynthesis , Proteoglycans/biosynthesis , Animals , Biomarkers , Cell Differentiation , Chondrocytes/cytology , Gene Expression Regulation, Developmental , Humans , Mice , RNA, Messenger/analysis , RNA, Messenger/biosynthesis
14.
Am J Med Genet ; 80(5): 510-3, 1998 Dec 28.
Article in English | MEDLINE | ID: mdl-9880218

ABSTRACT

Pseudoachondroplasia (PSACH) is an autosomal dominant dwarfing condition characterized by disproportionate short stature, joint laxity, and early-onset osteoarthrosis. PSACH is caused by mutations in the gene encoding cartilage oligomeric matrix protein (COMP). We are reporting on mutations in COMP in 12 patients with PSACH, including ten novel mutations. Eleven of the mutations are in exons 17A, 17B, and 18A, which encode the calcium-binding domains, and one mutation is in exon 19, which encodes part of the carboxy-terminal globular domain. Two of the mutations identified are the common delGAC(1430-1444) in exon 17B, which accounts for 36% of identified PSACH mutations. This report increases the range of mutations in COMP that cause PSACH and provides additional evidence for the importance of the calcium-binding domains and the globular domain to the function of COMP.


Subject(s)
Achondroplasia/genetics , Extracellular Matrix Proteins/genetics , Glycoproteins/genetics , Mutation , Achondroplasia/physiopathology , Amino Acid Sequence , Calcium-Binding Proteins/genetics , Calcium-Binding Proteins/metabolism , Cartilage Oligomeric Matrix Protein , Dwarfism/genetics , Extracellular Matrix Proteins/metabolism , Glycoproteins/metabolism , Humans , Matrilin Proteins , Molecular Sequence Data , Osteochondrodysplasias/genetics , Point Mutation , Transcription, Genetic
15.
Proc Natl Acad Sci U S A ; 91(24): 11457-61, 1994 Nov 22.
Article in English | MEDLINE | ID: mdl-7972084

ABSTRACT

We have cloned human cDNA encoding double-stranded RNA adenosine deaminase (DRADA). DRADA is a ubiquitous nuclear enzyme that converts multiple adenosines to inosines in double-helical RNA substrates without apparent sequence specificity. The A --> I conversion activity of the protein encoded by the cloned cDNA was confirmed by recombinant expression in insect cells. Use of the cloned DNA as a molecular probe documented sequence conservation across mammals and detected a single transcript of 7 kb in RNA of all human tissues analyzed. The deduced primary structure of human DRADA revealed a bipartite nuclear localization signal, three repeats of a double-stranded RNA binding motif, and the presence of sequences conserved in the catalytic center of other deaminases, including a cytidine deaminase involved in the RNA editing of apolipoprotein B. These structural properties are consistent with the enzymatic signature of DRADA, and strengthen the hypothesis that DRADA carries out the RNA editing of transcripts encoding glutamate-gated ion channels in brain.


Subject(s)
Adenosine Deaminase/genetics , RNA Editing , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Consensus Sequence , DNA Primers/chemistry , DNA, Complementary/genetics , Gene Expression , Genes , Humans , Molecular Sequence Data , RNA, Double-Stranded/metabolism , RNA, Messenger/genetics , RNA-Binding Proteins , Recombinant Proteins , Sequence Alignment , Sequence Homology, Amino Acid
16.
J Clin Anesth ; 6(6): 473-80, 1994.
Article in English | MEDLINE | ID: mdl-7880510

ABSTRACT

STUDY OBJECTIVE: To evaluate and compare the efficacy of various pretreatment agents to attenuate or prevent opioid-induced muscle rigidity using a well-established, previously described clinical protocol. DESIGN: Prospective, controlled, single-blind, partially randomized study. SETTING: Large medical center. PATIENTS: ASA physical status I-III patients undergoing elective surgical procedures of at least 3 hours' duration. INTERVENTIONS: The effect of pretreatment with nondepolarizing muscle relaxants (atracurium 40 micrograms/kg or metocurine 50 micrograms/kg), benzodiazepine agonists (diazepam 5 mg or midazolam 2.5 mg), or thiopental sodium 1 mg/kg on the increased muscle tone produced by alfentanil 175 micrograms/kg was compared with a control group (given no pretreatment). MEASUREMENTS AND MAIN RESULTS: Rigidity was assessed quantitatively by measuring the electromyographic activity of five muscle groups (biceps, intercostals, abdominals, quadriceps, and gastrocnemius). Rigidity also was rated qualitatively by attempts to initiate and maintain mask ventilation, attempts to flex an extremity, and the occurrence of myoclonic movements. Pretreatment with the two nondepolarizing muscle relaxants had no effect on the severe muscle rigidity produced by high-dose alfentanil. Whereas thiopental was only mildly effective, the benzodiazepines midazolam and diazepam significantly attenuated alfentanil rigidity (p < 0.05). CONCLUSION: This study suggests that benzodiazepine pretreatment is frequently, but not always, effective in preventing opioid-induced muscle rigidity.


Subject(s)
Alfentanil/adverse effects , Hypnotics and Sedatives/pharmacology , Muscle Rigidity/chemically induced , Neuromuscular Nondepolarizing Agents/pharmacology , Preanesthetic Medication , Abdominal Muscles/drug effects , Alfentanil/antagonists & inhibitors , Atracurium/administration & dosage , Atracurium/pharmacology , Diazepam/administration & dosage , Diazepam/pharmacology , Elective Surgical Procedures , Electromyography , Humans , Hypnotics and Sedatives/administration & dosage , Intercostal Muscles/drug effects , Midazolam/administration & dosage , Midazolam/pharmacology , Middle Aged , Muscle Rigidity/physiopathology , Muscle Rigidity/prevention & control , Muscle Tonus/drug effects , Muscle, Skeletal/drug effects , Neuromuscular Nondepolarizing Agents/administration & dosage , Prospective Studies , Single-Blind Method , Thiopental/administration & dosage , Thiopental/pharmacology , Tubocurarine/administration & dosage , Tubocurarine/analogs & derivatives , Tubocurarine/pharmacology
17.
J Biol Chem ; 269(18): 13480-9, 1994 May 06.
Article in English | MEDLINE | ID: mdl-8175781

ABSTRACT

The double-stranded RNA (dsRNA) adenosine deaminase (DRADA) deaminates adenosine residues to inosines and creates I-U mismatched base pairs in dsRNAs. Its involvement in RNA editing of glutamate-gated ion channel gene transcripts in mammalian brains has been proposed as one of the biological functions for this recently identified cellular enzyme. We purified a mixture of three forms, 93, 88, and 83 kDa, of bovine DRADA proteins, all likely to be active enzymes. We determined that DRADA has a native molecular mass of approximately 100 kDa, suggesting that the enzyme exists as a monomer. The purified enzyme was not inhibited by 2'-deoxycoformycin, a transition state analog inhibitor of adenosine deaminase and AMP deaminase, suggesting that the catalytic mechanism of DRADA might be different from that of other deaminases. DRADA binds specifically to dsRNA with a dissociation constant of 0.23 nM for a synthetic dsRNA, and the Michaelis constant is 0.85 nM. These values indicate that DRADA has a much higher affinity for its substrate than other deaminases such as adenosine deaminase and AMP deaminase. DRADA may need this extremely high affinity to catalyze efficiently the modification of relatively rare substrate RNAs in the cell nucleus.


Subject(s)
Adenosine Deaminase/isolation & purification , Cell Nucleus/enzymology , Liver/enzymology , Adenosine Deaminase/chemistry , Adenosine Deaminase/metabolism , Adenosine Deaminase Inhibitors , Animals , Cattle , Chelating Agents/pharmacology , Chromatography, Gel , Chromatography, Ion Exchange , Electrophoresis, Polyacrylamide Gel , Kinetics , Molecular Weight , RNA-Binding Proteins , Substrate Specificity , Zinc/metabolism
18.
J Leukoc Biol ; 53(3): 240-8, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8454947

ABSTRACT

Estrogen and progesterone induce production of macrophage colony-stimulating factor (CSF-1) by uterine epithelial cells, and CSF-1 is produced in the uterus during pregnancy in mice. CSF-1 is a lineage-specific stimulator of macrophage proliferation, chemotaxis, and function. High concentrations of macrophages accumulate in the uterus during pregnancy. Experiments were conducted to determine whether a relationship exists between intrauterine CSF-1 production and the number and distribution of uterine macrophages during pregnancy in mice. The study demonstrated that on day 1 of pregnancy CSF-1 bioactivity levels were high. The number of macrophages in the uterus was also high on days 1 and 2, and macrophages were concentrated at epithelial surfaces. The decrease in CSF-1 bioactivity seen between days 1 and 2 was followed by a decrease in the macrophage concentration. An increase in CSF-1 bioactivity on day 4 was followed by an increase in the concentration of intrauterine macrophages. During the immediate postimplantation period, macrophages were detected primarily in the myometrium and deep endometrium and CSF-1 bioactivity was undetectable. During the second half of pregnancy, when CSF-1 concentrations were very high, the macrophage concentration was also very high and large numbers of macrophages were detected in association with epithelia. The data confirmed the existence of a direct relationship between intrauterine CSF-1 and macrophage accumulation and suggested that macrophages are attracted to epithelial surfaces by CSF-1.


Subject(s)
Macrophage Colony-Stimulating Factor/biosynthesis , Pregnancy, Animal/metabolism , Uterus/metabolism , Animals , Epithelial Cells , Female , Macrophage Colony-Stimulating Factor/genetics , Macrophage Colony-Stimulating Factor/metabolism , Macrophages/metabolism , Mice , Pregnancy , RNA, Messenger/analysis , Uterus/cytology
19.
Science ; 259(5099): 1277-82, 1993 Feb 26.
Article in English | MEDLINE | ID: mdl-17732247

ABSTRACT

The Mediterranean Sea produces a salty, dense outflow that is strongly modified by entrainment as it first begins to descend the continental slope in the eastern Gulf of Cadiz. The current accelerates to 1.3 meters per second, which raises the internal Froude number above 1, and is intensely turbulent through its full thickness. The outflow loses about half of its density anomaly and roughly doubles its volume transport as it entrains less saline North Atlantic Central water. Within 100 kilometers downstream, the current is turned by the Coriolis force until it flows nearly parallel to topography in a damped geostrophic balance. The mixed Mediterranean outflow continues westward, slowly descending the continental slope until it becomes neutrally buoyant in the thermocline where it becomes an important water mass.

20.
J Reprod Fertil ; 97(1): 83-9, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8464030

ABSTRACT

Interleukin 1 (IL-1), IL-6 and tumour necrosis factor alpha (TNF-alpha) are expressed in the mouse uterus on days 1-3 of pregnancy. Cytokine production is temporally associated with the post-mating intrauterine acute inflammatory response. In this study, IL-1, IL-6 and TNF-alpha were detected in the uterus of pregnant mice from day 3 to day 9, using northern blotting, bioassays and immunocytochemistry. IL-1 bioactivity increased from a low concentration on day 3 to a peak between days 4 and 5 and decreased to low concentrations on days 7 and 8. Blastocyst implantation occurs late on day 4. IL-6 bioactivity was high from day 3 to day 9 and activity was maximal on days 5 and 6. TNF-alpha bioactivity increased from its lowest concentration on day 3 to a peak on day 8. Although changes in bioactivity concentrations occurred at different times from changes in mRNA concentrations, the changes were approximately parallel. Translation of mRNA into an immunologically detectable product was confirmed using immunocytochemistry with polyclonal anti-cytokine antibodies. We conclude that the cytokines IL-1, IL-6 and TNF-alpha are produced in the uterus during the peri-implantation period of pregnancy in mice. Changes in cytokine concentrations suggested the existence of some form of regulated expression.


Subject(s)
Embryo Implantation , Interleukin-6/biosynthesis , Monokines/biosynthesis , Pregnancy, Animal/metabolism , Uterus/metabolism , Animals , Blotting, Northern , Female , Immunohistochemistry , In Situ Hybridization , Interleukin-1/biosynthesis , Mice , Mice, Inbred Strains , Pregnancy , Tumor Necrosis Factor-alpha/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...